Malin Corporation | MLC - Net Income


Malin Corporation reported EUR-1.1M in Net Income for its fiscal semester ending in December of 2023.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
ALKERMES USD 501K 66.98M Jun/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Eurofins Scientific SE EUR 302M 108.3M Jun/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
IQVIA Holdings USD 350M 94M Sep/2026
Lonza CHF 426M 119M Jun/2025
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD 108M 38M Jun/2026
Ovoca Bio EUR 4.42M 5.19M Dec/2025
Revvity USD 51.82M 11.1M Jun/2026
Tectonic Therapeutic USD -25.24M 6.02M Mar/2026
Viatris USD -118.8M 295.2M Jun/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026